FGH Biotech Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.08M
Latest Deal Amount
  • Investors
  • 2

FGH Biotech General Information


Developer of small molecule drug designed to treat metabolic disorders and cancer. The company's drugs target the master regulatory switch for fat production, known as sterol regulatory element-binding proteins (SREBP), enabling physicians to treat obesity, non-alcoholic fatty liver disease, type II diabetes and lipid disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 414 Thamer Circle
  • Houston, TX 77024
  • United States
+1 (713) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FGH Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 19-May-2018 $2.08M 00.000 Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Angel (individual) 06-Nov-2015 Cancelled Generating Revenue
1. Grant 01-Jan-2014 $1.84M Completed Generating Revenue
To view FGH Biotech’s complete valuation and funding history, request access »

FGH Biotech Executive Team (4)

Name Title Board Seat Contact Info
Joe Wakil President & Board Member
Lufti Abu-Elheiga Ph.D Co-Founder, Board Member & Vice President, Research & Development
Salih Wakil Co-Founder, President & Board Member
Motonari Uesugi Ph.D Co-Founder
To view FGH Biotech’s complete executive team members history, request access »

FGH Biotech Board Members (3)

Name Representing Role Since
Adam Kuspa FGH Biotech Board Member 000 0000
Joe Wakil FGH Biotech President & Board Member 000 0000
Salih Wakil FGH Biotech Co-Founder, President & Board Member 000 0000
To view FGH Biotech’s complete board members history, request access »

FGH Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
BCM Technologies Venture Capital Minority 000 0000 000000 0
To view FGH Biotech’s complete investors history, request access »